Implantable and transcutaneous continuous glucose monitoring system: a randomized cross over trial comparing accuracy, efficacy and acceptance.
J Endocrinol Invest
; 45(1): 115-124, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-34196924
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Patient Acceptance of Health Care
/
Diabetes Mellitus, Type 1
/
Glycemic Control
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Year:
2022
Type:
Article